MA55074A - Dérivés de pyrazolopyridine utilisés comme inhibiteurs de pask - Google Patents
Dérivés de pyrazolopyridine utilisés comme inhibiteurs de paskInfo
- Publication number
- MA55074A MA55074A MA055074A MA55074A MA55074A MA 55074 A MA55074 A MA 55074A MA 055074 A MA055074 A MA 055074A MA 55074 A MA55074 A MA 55074A MA 55074 A MA55074 A MA 55074A
- Authority
- MA
- Morocco
- Prior art keywords
- pask
- inhibitors
- derivatives used
- pyrazolopyridine derivatives
- pyrazolopyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1902490.0A GB201902490D0 (en) | 2019-02-25 | 2019-02-25 | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA55074A true MA55074A (fr) | 2022-01-05 |
Family
ID=65998935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA055074A MA55074A (fr) | 2019-02-25 | 2020-02-17 | Dérivés de pyrazolopyridine utilisés comme inhibiteurs de pask |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20220144823A1 (fr) |
| EP (1) | EP3931191B1 (fr) |
| JP (1) | JP2022525121A (fr) |
| KR (1) | KR20210134001A (fr) |
| CN (1) | CN113474344A (fr) |
| AR (1) | AR124749A1 (fr) |
| AU (1) | AU2020229041A1 (fr) |
| BR (1) | BR112021016642A2 (fr) |
| CA (1) | CA3130154A1 (fr) |
| CO (1) | CO2021010485A2 (fr) |
| ES (1) | ES2963409T3 (fr) |
| GB (1) | GB201902490D0 (fr) |
| IL (1) | IL285751A (fr) |
| MA (1) | MA55074A (fr) |
| MX (1) | MX2021010093A (fr) |
| SG (1) | SG11202109157TA (fr) |
| TW (1) | TW202045505A (fr) |
| WO (1) | WO2020173739A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022070288A1 (fr) * | 2020-09-30 | 2022-04-07 | 旭化成ファーマ株式会社 | Composé bicyclique contenant de l'azote |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002088107A1 (fr) * | 2001-04-26 | 2002-11-07 | Eisai Co., Ltd. | Compose azote a anneaux condenses possedant un groupe pyrazolyle et servant de substituant, et composition medicale le comprenant |
| US10392389B2 (en) * | 2012-10-25 | 2019-08-27 | Bioenergenix Llc | Heterocyclic compounds for the inhibition of PASK |
-
2019
- 2019-02-25 GB GBGB1902490.0A patent/GB201902490D0/en not_active Ceased
-
2020
- 2020-02-17 KR KR1020217030814A patent/KR20210134001A/ko unknown
- 2020-02-17 CA CA3130154A patent/CA3130154A1/fr active Pending
- 2020-02-17 WO PCT/EP2020/054122 patent/WO2020173739A1/fr unknown
- 2020-02-17 US US17/433,503 patent/US20220144823A1/en active Pending
- 2020-02-17 CN CN202080016700.3A patent/CN113474344A/zh active Pending
- 2020-02-17 BR BR112021016642A patent/BR112021016642A2/pt unknown
- 2020-02-17 AU AU2020229041A patent/AU2020229041A1/en not_active Abandoned
- 2020-02-17 MA MA055074A patent/MA55074A/fr unknown
- 2020-02-17 JP JP2021555034A patent/JP2022525121A/ja active Pending
- 2020-02-17 EP EP20706194.6A patent/EP3931191B1/fr active Active
- 2020-02-17 SG SG11202109157TA patent/SG11202109157TA/en unknown
- 2020-02-17 ES ES20706194T patent/ES2963409T3/es active Active
- 2020-02-17 MX MX2021010093A patent/MX2021010093A/es unknown
- 2020-02-21 AR ARP200100485A patent/AR124749A1/es unknown
- 2020-02-24 TW TW109105861A patent/TW202045505A/zh unknown
-
2021
- 2021-08-10 CO CONC2021/0010485A patent/CO2021010485A2/es unknown
- 2021-08-22 IL IL285751A patent/IL285751A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL285751A (en) | 2021-10-31 |
| AR124749A1 (es) | 2023-05-03 |
| SG11202109157TA (en) | 2021-09-29 |
| EP3931191B1 (fr) | 2023-10-04 |
| CA3130154A1 (fr) | 2020-09-03 |
| MX2021010093A (es) | 2021-09-21 |
| AU2020229041A1 (en) | 2021-10-21 |
| CN113474344A (zh) | 2021-10-01 |
| BR112021016642A2 (pt) | 2021-11-03 |
| GB201902490D0 (en) | 2019-04-10 |
| EP3931191A1 (fr) | 2022-01-05 |
| TW202045505A (zh) | 2020-12-16 |
| US20220144823A1 (en) | 2022-05-12 |
| ES2963409T3 (es) | 2024-03-27 |
| JP2022525121A (ja) | 2022-05-11 |
| CO2021010485A2 (es) | 2021-08-19 |
| KR20210134001A (ko) | 2021-11-08 |
| WO2020173739A1 (fr) | 2020-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43753A (fr) | Dérivés 1-cyano-pyrrolidine comme inhibiteurs de dbu | |
| DK3873903T3 (da) | Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere | |
| MA45591A (fr) | Dérivés de 1,3-dihydroxy-phényle utiles comme immunomodulateurs | |
| MA49888A (fr) | Composés macrocycliques utilisés en tant qu'inhibiteurs de kinase ros1 | |
| MA44860A (fr) | Composés hétérocycliques utilisés comme immunomodulateurs | |
| EA201791563A1 (ru) | Замещенные нуклеозидные производные, полезные в качестве агентов против рака | |
| MA52891A (fr) | Dérivés aza-indoliques utilisés comme inhibiteurs de rho-kinase | |
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| MA46531A (fr) | Dérivés d'azétidine ou de cyclobutane 1,3-disubstitués utilisés comme inhibiteurs de la prostaglandine d synthase hématopoïétique (h-pgds) | |
| MA41803A (fr) | Dérivés amino-indazoles utilisés comme inhibiteurs des canaux sodiques | |
| MA45918A (fr) | Dérivés hétérocycliques bicycliques condensés utilisés comme pesticides | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| EP4067359A4 (fr) | Composés de pyrimidoimidazole utilisés en tant qu'inhibiteurs de la dna-pk | |
| MA51133A (fr) | Dérivés de pyrrole utilisés en tant qu'inhibiteurs d'acc | |
| MA51285A (fr) | Dérivés d'azaindole comme inhibiteurs de rho-kinase | |
| MA50398A (fr) | Dérivés d'imidazole condensés, substitués par des groupes hydroxy tertiaires, utilisés comme inhibiteurs de pi3k-gamma | |
| DK3952995T3 (da) | Bicykliske heteroarylderivater som ectonukleotidpyrophosphatase-phosphodiesterase-1-hæmmere | |
| EP3703692A4 (fr) | Nouveaux composés de tétrahydroquinoline substitués utilisés en tant qu'inhibiteurs de l'indoléamine 2,3-dioxygénase (ido) | |
| MA50537A (fr) | Composés deutérés utilisés comme immunomodulateurs | |
| EP3694502A4 (fr) | Nouveaux composés cyclobutylbenzene substitués utilisés en tant qu'inhibiteurs de l'indoléamine 2,3-dioxygénase (ido) | |
| CY1123406T1 (el) | Παραγωγο τριαζολοπυραζινονης χρησιμο ως ενας ανθρωπινος pde1 αναστολεας | |
| EA201990952A1 (ru) | ПИРИДОНОВОЕ СОЕДИНЕНИЕ В КАЧЕСТВЕ ИНГИБИТОРА c-Met | |
| MA41938A (fr) | Dérivés hétérocycliques amino-substitués utilisés comme inhibiteurs des canaux sodiques | |
| MA55074A (fr) | Dérivés de pyrazolopyridine utilisés comme inhibiteurs de pask | |
| EP3982959A4 (fr) | Nouveaux composés de tétrahydroquinoléine substitués en tant qu'inhibiteurs de l'indoléamine 2,3-dioxygénase (ido) |